01/22/2026
New research from Aotearoa New Zealand is adding powerful patient voices to the conversation around endometriosis care.
An observational cohort study led by researchers Charles Henry, Laura Cooper, and Hannah Adler explored how patients with endometriosis perceive the impact of medicinal cannabis on chronic pelvic pain and daily functioning. Drawing from self-reported experiences, participants shared improvements in pain levels, mobility, emotional wellbeing, and overall quality of life—though responses varied from person to person.
The study highlights that while cannabis isn’t a one-size-fits-all solution, many patients found meaningful symptom relief using non-smokable forms like oils, capsules, and edibles. Researchers also noted the importance of personalized treatment plans, supportive healthcare environments, and reducing stigma so patients can openly discuss cannabis as a therapeutic option.
Published in BMC Complementary Medicine and Therapies, this research reinforces the growing call for patient-centered, evidence-informed approaches to chronic pain management and for continued research into medicinal cannabis as a viable option for endometriosis care.
